Delavar Reza, Heidarianpour Ali
Exercise Physiology Department, Faculty of Physical Education and Sport Sciences, Bu-Ali Sina University, Hamadan, IR Iran.
Iran Red Crescent Med J. 2016 May 11;18(9):e31737. doi: 10.5812/ircmj.31737. eCollection 2016 Sep.
Diabetes mellitus (types 1 and 2) leads to secondary complications such as neuropathy, which reduce a patient's quality of life. Apelin and its receptor, APJ, have been shown to have antinociceptive effects and to decrease blood glucose levels.
The present experimental study was conducted in Iran and investigated the role of apelin, which is used to manage type 1 diabetes mellitus, during exercise training.
Male Wistar rats (n = 36) were assigned by simple random allocation to six groups (n = 6): non-diabetic (ND), diabetic (D), sedentary non-diabetic (SND), sedentary diabetic (SD), exercise non-diabetic (END), and exercise diabetic (ED). Diabetes was induced by a single subcutaneous injection of streptozotocin (50 mg/kg). Exercise training consisted of treadmill running 60 minutes/day × 5 days/week for 10 weeks. The tail-flick test was used to assess the thermal pain threshold, and an apelin enzyme immunoassay kit was utilized to assess plasma apelin levels.
Plasma apelin level was higher (0.3 vs. 0.1, P < 0.0001) and the tail-flick latency was lower (2.2 vs. 3.8, P < 0.0001) in the D group than in the ND group. After the training program, plasma apelin levels decreased in the exercise groups, and the tail-flick latency increased in the ED group. No correlation was found between apelin blood concentrations and tail-flick latency following the training program in the ED group.
These findings suggest that apelin does not play any significant role in regulating the pain threshold in type 1 diabetes mellitus during exercise training.
1型和2型糖尿病会引发诸如神经病变等继发性并发症,这些并发症会降低患者的生活质量。已证实阿片肽及其受体APJ具有抗伤害感受作用,并能降低血糖水平。
本实验研究在伊朗开展,旨在探究用于治疗1型糖尿病的阿片肽在运动训练过程中的作用。
将36只雄性Wistar大鼠通过简单随机分配法分为6组(每组n = 6):非糖尿病组(ND)、糖尿病组(D)、久坐非糖尿病组(SND)、久坐糖尿病组(SD)、运动非糖尿病组(END)和运动糖尿病组(ED)。通过单次皮下注射链脲佐菌素(50 mg/kg)诱导糖尿病。运动训练包括在跑步机上每天跑步60分钟,每周5天,持续10周。采用甩尾试验评估热痛阈值,并使用阿片肽酶免疫分析试剂盒评估血浆阿片肽水平。
与ND组相比,D组的血浆阿片肽水平更高(0.3对0.1,P < 0.0001),甩尾潜伏期更低(2.2对3.8,P < 0.0001)。训练计划结束后,运动组的血浆阿片肽水平降低,ED组的甩尾潜伏期增加。在ED组的训练计划后,未发现阿片肽血药浓度与甩尾潜伏期之间存在相关性。
这些研究结果表明,在运动训练期间,阿片肽在调节1型糖尿病患者的痛阈方面未发挥任何显著作用。